Women taking antidepressants who are thinking about getting pregnant might consider tapering or discontinuing drug therapy if they have experienced only mild or no symptoms for at least 6 months, depending on their psychiatric history, according to a new report released Aug. 21 on the treatment of depression during pregnancy.
Data detailing a recent drop in the age-adjusted death rate and other positive trends regarding life expectancy and deaths in the United States were released in a report by the Centers for Disease Control and Prevention on Aug. 19.
The human papillomavirus vaccine Gardasil generated 12,424 adverse event reports over a 2.4-year period, however, only syncope and venous thromboembolism exceeded the expected background rates.
September is National Preparedness Month. In preparation, this month’s Breezing Along with the RML will focus on Emergency Preparedness. Jim Honour will be reviewing the programming for emergency preparedness in the Midcontinental Region with his presentation: Pandemonium? : Programming the Prescription. He’ll point out some emergency planning programming this past year, including a meeting to explore partnering community based organizations with librarians and culminating with Dan Wilson and the MCR staff presenting the Ten Step Emergency Plan workshop at the Midcontinental Medical Library Association meeting in Breckenridge in the fall. Dana Abbey and guest presenters Sandy Decker from Missouri Baptist Medical Center and Deborah Weaver from The Children’s Hospital in Co…
In patients attending a general dermatology practice, most melanomas diagnosed during a 3-year period were not the presenting complaint, but were only discovered because a dermatologist performed a full-body skin examination, according to a report in the August issue of the Archives of Dermatology.
Manufacturing issues may limit the number of vaccine doses against novel influenza A(H1N1) that will be available when immunization programs begin around mid-October, officials from the Department of Health and Human Services told members of the National Biodefense Science Board in a public teleconference on Aug. 14.
Thank you for joining us during the PubMed Redesign Update web conference yesterday, August 11, 2009. We apologize if you were not able to join the meeting due to the 125 audio connection limitations, and for your patience during some rather odd audio disturbances during the session.
The audiovisual recording of the session that lasts just a little over a half hour is now available at https://webmeeting.nih.gov/p66847164/ PowerPoint slides from the Medical Library Association Online Users’ Meeting that are similar to yesterday’s presentation are available in the Editor’s Notes of the June 10, 2009 NLM Technical Bulletin
Percutaneous closure of the left atrial appendage using the WATCHMAN device may be a viable alternative to chronic warfarin therapy for stroke prophylaxis in some patients with atrial fibrillation, according to researchers in the PROTECT AF trial.
Two new final regulations issued by the Food and Drug Administration clarify and expand the means for patients with serious or life-threatening conditions to access investigational drugs.
